| Nichole Baucan, DNP | |
|
806 Jefferson Ter, New Iberia, LA 70560-5727 | |
| (337) 365-4945 | |
| (337) 367-3917 |
| Full Name | Nichole Baucan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 806 Jefferson Ter, New Iberia, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093428542 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 227609 (Louisiana) | Primary |
| Entity Name | Iberia Comprehensive Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922046549 PECOS PAC ID: 6204817828 Enrollment ID: O20050809000029 |
News Archive
According to a new report from the University of Wollongong in New South Wales, 90% of 12 to 17-year-olds in the state have used alcohol; the report also reveals that the level of risky drinking by adults has decreased from 50% to 30% in men and 37 to 27% in women.
Protherics PLC today announced the initiation of a phase 2a proof-of-concept study of Prolarix, a targeted prodrug chemotherapy being developed for the treaent of primary liver cancer (hepatocellular carcinoma or "HCC"). This follows promising data from a phase 1 study of Prolarix, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA on 2 June 2008.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care settings.
New guidelines that classified more children as having elevated blood pressure are better at predicting which kids are likely to develop heart disease when they reach adulthood, according to new research in the American Heart Association's journal Hypertension.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nichole Baucan, DNP 806 Jefferson Ter, New Iberia, LA 70560-5727 Ph: (337) 365-4945 | Nichole Baucan, DNP 806 Jefferson Ter, New Iberia, LA 70560-5727 Ph: (337) 365-4945 |
News Archive
According to a new report from the University of Wollongong in New South Wales, 90% of 12 to 17-year-olds in the state have used alcohol; the report also reveals that the level of risky drinking by adults has decreased from 50% to 30% in men and 37 to 27% in women.
Protherics PLC today announced the initiation of a phase 2a proof-of-concept study of Prolarix, a targeted prodrug chemotherapy being developed for the treaent of primary liver cancer (hepatocellular carcinoma or "HCC"). This follows promising data from a phase 1 study of Prolarix, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA on 2 June 2008.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care settings.
New guidelines that classified more children as having elevated blood pressure are better at predicting which kids are likely to develop heart disease when they reach adulthood, according to new research in the American Heart Association's journal Hypertension.
› Verified 4 days ago
Mr. Jonathan A Seghorn, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 806 Jefferson Ter, New Iberia, LA 70560 Phone: 337-365-4945 | |
Mrs. Alison T. Cantrall, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2309 E Main St, Suite 301, New Iberia, LA 70560 Phone: 337-364-4415 Fax: 337-364-4495 | |
Allyson Hebert, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2308 E Main St Ste B, New Iberia, LA 70560 Phone: 337-369-3683 Fax: 877-796-6140 | |
Ashley Robicheaux, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1110 E Saint Peter St, New Iberia, LA 70560 Phone: 337-364-1166 | |
Erin Elizabeth Perek, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1110 E Saint Peter St, New Iberia, LA 70560 Phone: 337-364-1166 Fax: 337-364-7090 | |
Lisa L Freyou, ACNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 500 N Lewis St, Suite 100, New Iberia, LA 70563 Phone: 337-367-5200 Fax: 337-369-3074 |